| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 86,930,560 | 92,079,816 | 80,996,444 | | Cost of Revenue | 48,764,342 | 52,047,867 | 45,887,027 | | | Gross Profit | 38,166,218 | 40,031,949 | 35,109,418 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 30,373,396 | 32,456,824 | 29,517,947 | | Non Recurring | (2,131,466) | (153,182) | (1,441,768) | | Others |
-
| (57,443) | 52,812 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 9,924,288 | 7,785,749 | 6,980,426 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (429,959) | (166,438) | 470,027 | | Earnings Before Interest And Taxes | 8,947,366 | 7,698,848 | 7,183,752 | | Interest Expense | 4,081,082 | 4,087,298 | 3,745,691 | | Income Before Tax | 4,866,284 | 3,611,551 | 3,438,061 | | Income Tax Expense | 2,013,052 | 2,023,765 | (924,210) | | Minority Interest | (762,648) |
-
| (537,362) | | | | Net Income From Continuing Ops | 2,090,585 | 1,587,786 | 4,250,046 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,090,585 | 1,587,786 | 4,250,046 | | Preferred Stock And Other Adjustments |
-
| (749,706) |
-
| | | Net Income Applicable To Common Shares | $2,090,585 | $838,080 | $4,250,046 |
|
0.29% Nasdaq 
Income Statement
